Global Blood Therapeutics, Inc. Business Finance Contracts & Agreements

20 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Supplemental Indenture to 1.875% Convertible Senior Notes Due 2028 between Global Blood Therapeutics, Inc. and U.S. Bank Trust Company, N.A.
Indenture Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2022
Global Blood Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan
Stock Agreements
Global Blood Therapeutics, Inc.
Biotechnology
DE
2021
Global Blood Therapeutics, Inc. Amended and Restated 2015 Employee Stock Purchase Plan
Stock Agreements
Global Blood Therapeutics, Inc.
Biotechnology
DE
2020
Description of Global Blood Therapeutics, Inc. Common Stock Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Global Blood Therapeutics, Inc.
Biotechnology
DE
2020
First Amendment to Amended and Restated Investors’ Rights Agreement by Global Blood Therapeutics, Inc. and Investors
Investor Rights Agreements
Global Blood Therapeutics, Inc.
Biotechnology
CA
2016
Global Blood Therapeutics, Inc. 2015 Employee Stock Purchase Plan
Stock Agreements
Global Blood Therapeutics, Inc.
Biotechnology
DE
2015
Global Blood Therapeutics, Inc. Common Stock Certificate Specimen
Stock Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2015
Assignment and Assumption of Lease Agreement between Myokardia, Inc. and Global Blood Therapeutics, Inc. for 400 East Jamie Court
Assignment Agreements
Global Blood Therapeutics, Inc.
Biotechnology
DE
2015
Global Blood Therapeutics, Inc. 2012 Stock Option and Grant Plan
Stock Agreements
Global Blood Therapeutics, Inc.
Biotechnology
DE
2015
Amended and Restated Investors' Rights Agreement between Global Blood Therapeutics, Inc. and Investors (December 22, 2014)
Investor Rights Agreements
Global Blood Therapeutics, Inc.
Biotechnology
CA
2015
Capped Call Transaction Confirmation between Global Blood Therapeutics, Inc. and [Dealer]
Financing Agreements
Global Blood Therapeutics, Inc.
Biotechnology
DE
2021
Indenture Agreement for 1.875% Convertible Senior Notes due 2028 between Global Blood Therapeutics, Inc. and U.S. Bank National Association
Indenture Agreements
Global Blood Therapeutics, Inc.
Biotechnology
DE
2021
Loan Agreement between Global Blood Therapeutics, Inc. and BioPharma Credit PLC & BioPharma Credit Investments V (Master) LP (December 17, 2019)
Loan Agreements
Global Blood Therapeutics, Inc.
Biotechnology
NY
2020
Underwriting Agreement between Global Blood Therapeutics, Inc. and Cantor Fitzgerald & Co. (June 26, 2019)
Underwriting Agreements
Global Blood Therapeutics, Inc.
Biotechnology
NY
2019
Underwriting Agreement between Global Blood Therapeutics, Inc. and Cantor Fitzgerald & Co. (December 7, 2018)
Underwriting Agreements
Global Blood Therapeutics, Inc.
Biotechnology
NY
2018
Underwriting Agreement between Global Blood Therapeutics, Inc. and Wells Fargo Securities, LLC (March 8, 2018)
Underwriting Agreements
Global Blood Therapeutics, Inc.
Biotechnology
NY
2018
Underwriting Agreement between Global Blood Therapeutics, Inc. and Cantor Fitzgerald & Co. (December 15, 2017)
Underwriting Agreements
Global Blood Therapeutics, Inc.
Biotechnology
NY
2017
Underwriting Agreement between Global Blood Therapeutics, Inc. and Cantor Fitzgerald & Co. (February 21, 2017)
Underwriting Agreements
Global Blood Therapeutics, Inc.
Biotechnology
NY
2017
Underwriting Agreement between Global Blood Therapeutics, Inc. and J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, and Other Underwriters
Underwriting Agreements
Global Blood Therapeutics, Inc.
Biotechnology
NY
2016
Underwriting Agreement between Global Blood Therapeutics, Inc. and Morgan Stanley & Co. LLC, Goldman, Sachs & Co. (2015)
Underwriting Agreements
Global Blood Therapeutics, Inc.
Biotechnology
NY
2015